HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mentholatum PHisoderm Buy Strengthens Firm’s U.S. Presence

This article was originally published in The Rose Sheet

Executive Summary

The Mentholatum Company's purchase of Chattem's pHisoderm brand provides the firm a platform to compete in the U.S. women's skin care market, the Rohto Pharmaceutical division said

You may also be interested in...



PHisoderm Formulas Create “Complete Skin Care System”

Mentholatum is rounding out its pHisoderm facial care offerings with the launch of four new products that create a "complete skin care system," according to the company

PHisoderm Formulas Create “Complete Skin Care System”

Mentholatum is rounding out its pHisoderm facial care offerings with the launch of four new products that create a "complete skin care system," according to the company

Chattem Q2 Net Sales Hop 5% On Bullfrog, Gold Bond

Strong sales of Bullfrog Mosquito Coast led a 25% increase in revenue for the sun care franchise during the second quarter, Chattem reported July 10

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013572

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel